Docefrez

Docefrez is a chemotherapy medication used primarily in the treatment of various types of cancer. It is a formulation of docetaxel, which is a taxane used to inhibit cell division by disrupting the microtubular network within the cell. Docefrez is administered intravenously and is commonly used in the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and head and neck cancer.

Mechanism of Action

Docefrez works by stabilizing the microtubules in the cell, preventing their disassembly which is necessary for cell division. This action inhibits the mitotic process, leading to cell death. The drug specifically targets rapidly dividing cells, a characteristic of cancer cells, making it effective in slowing down or stopping the growth of tumors.

Indications

Docefrez is indicated for the treatment of:

• Breast cancer
• Non-small cell lung cancer
• Prostate cancer
• Gastric cancer
• Head and neck cancer

Administration

Docefrez is administered through an intravenous infusion. The dosage and frequency of administration depend on the type of cancer being treated, the stage of the disease, and the patient's overall health and response to the treatment.

Side Effects

Common side effects of Docefrez include:

• Neutropenia
• Anemia
• Nausea
• Vomiting
• Diarrhea
• Fatigue
• Alopecia

Serious side effects may include severe allergic reactions, fluid retention, and neuropathy.

Precautions

Patients receiving Docefrez should be monitored for signs of bone marrow suppression, liver function, and allergic reactions. Pre-medication with corticosteroids is often recommended to reduce the risk of hypersensitivity reactions and fluid retention.

Related Pages

• Docetaxel
• Chemotherapy
• Breast cancer
• Non-small cell lung cancer
• Prostate cancer
• Gastric cancer
• Head and neck cancer